Semler Scientific faces class action lawsuit over alleged securities violations.
ByAinvest
Tuesday, Oct 7, 2025 7:28 am ET1min read
SMLR--
According to the Complaint, Semler Scientific discussed potential violations of the False Claims Act in hypothetical terms during the class period but failed to disclose a DOJ investigation into such violations. This led to materially false and misleading statements, causing investors to suffer damages when the true details emerged. The class period for this lawsuit is from March 10, 2021, to April 15, 2025, inclusive.
Investors are urged to contact the Schall Law Firm [1], the DJS Law Group [2], and Bronstein, Gewirtz & Grossman, LLC [3] before the deadline of October 29, 2025, to discuss possible lead plaintiff appointments. Participation in the class action does not require appointment as a lead plaintiff, and there is no cost to investors.
The Schall Law Firm, the DJS Law Group, and Bronstein, Gewirtz & Grossman, LLC are experienced in securities class actions and shareholder rights litigation. They specialize in representing investors and recovering damages on behalf of those who have suffered losses due to securities fraud.
Semler Scientific is facing a class action lawsuit for alleged violations of the Securities Exchange Act of 1934 and Rule 10b-5. The lawsuit claims the company made false and misleading statements to shareholders, including discussions about hypothetical violations of the False Claims Act without disclosing a DOJ investigation. Investors who purchased shares during the class period (March 10, 2021 to April 15, 2025) are encouraged to contact the firm about possible lead plaintiff appointments.
Semler Scientific, Inc. (NASDAQ: SMLR) is facing a class action lawsuit for alleged violations of the Securities Exchange Act of 1934 and Rule 10b-5. The lawsuit, filed by several law firms, claims that the company made false and misleading statements to shareholders, including discussions about hypothetical violations of the False Claims Act without disclosing a Department of Justice (DOJ) investigation. Investors who purchased shares during the class period (March 10, 2021 to April 15, 2025) are encouraged to contact the firms involved to discuss their rights.According to the Complaint, Semler Scientific discussed potential violations of the False Claims Act in hypothetical terms during the class period but failed to disclose a DOJ investigation into such violations. This led to materially false and misleading statements, causing investors to suffer damages when the true details emerged. The class period for this lawsuit is from March 10, 2021, to April 15, 2025, inclusive.
Investors are urged to contact the Schall Law Firm [1], the DJS Law Group [2], and Bronstein, Gewirtz & Grossman, LLC [3] before the deadline of October 29, 2025, to discuss possible lead plaintiff appointments. Participation in the class action does not require appointment as a lead plaintiff, and there is no cost to investors.
The Schall Law Firm, the DJS Law Group, and Bronstein, Gewirtz & Grossman, LLC are experienced in securities class actions and shareholder rights litigation. They specialize in representing investors and recovering damages on behalf of those who have suffered losses due to securities fraud.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet